
"Suicidal Ideation and Hair Loss: Safety of GLP-1 Weight Loss Drugs Evaluated by FDA"
The FDA is investigating potential side effects of GLP-1 medications, including suicidal ideation, hair loss, and aspiration. While a recent study found no link between semaglutide, the active ingredient in drugs like Ozempic and Wegovy, and suicidal ideation, previous research has shown potential side effects such as gastrointestinal issues and increased heart rate. Experts suggest screening for psychological disorders before prescribing these medications and emphasize the importance of continuous monitoring and discussion of potential side effects with a healthcare provider.






